Publications by authors named "Kouki Inai"

Claim this Profile
T
Telepathology in intraoperative frozen section consultation of breast cancer sentinel node biopsy in Fukushima, Japan following the 2011 triple disaster: diagnostic accuracy and required time during the early implementation phase.
Hiroaki Kawakami, Akihiko Ozaki, Yudai Kaneda, Shigeyuki Asano, Kouki Inai

Rural Remote Health· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The experience of introducing telepathology in Mongolia.
Batchimeg Tsedenbal, Enkhee Ochirjav, Ariun-Uils Gankhuyag, Bolortuya Dorj, Saruul Gerelchuluun, Kouki Inai

J Pathol Inform· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor.
Tomoaki Naka, Yutaka Hatanaka, Yukiko Tabata, Akira Takasawa, Hideo Akiyama, Kouki Inai

Diagnostics (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to 'MUC4 staining in sarcomatoid carcinomas' by Berg et al.
Vishwa Jeet Amatya, Kei Kushitani, Amany Sayed Mawas, Yoshihiro Miyata, Morihito Okada, Kouki Inai

Mod Pathol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia.
Kei Kushitani, Vishwa Jeet Amatya, Amany Sayed Mawas, Rui Suzuki, Yoshihiro Miyata, Kouki Inai

Oncol Lett· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma.
Masatsugu Kuraoka, Vishwa J Amatya, Kei Kushitani, Amany S Mawas, Yoshihiro Miyata, Kouki Inai

Am J Surg Pathol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Vishwa Jeet Amatya, Kei Kushitani, Amany Sayed Mawas, Yoshihiro Miyata, Morihito Okada, Kouki Inai

Mod Pathol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.
Kei Kushitani, Vishwa J Amatya, Yasuko Okada, Yuya Katayama, Amany S Mawas, Kouki Inai

Histopathology· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion.
Katsuya Kato, Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Yukio Takeshima, Kouki Inai

Eur J Radiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal pleural mesothelioma in Japan (2003-2008): evaluation of computed tomography findings.
Katsuya Kato, Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Yukio Takeshima, Kouki Inai

Jpn J Radiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Fatal pleural mesothelioma in Japan (2003-2008): evaluation of computed tomography findings.
Katsuya Kato, Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Yukio Takeshima, Kouki Inai

Jpn J Radiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computed Tomographic Features of Malignant Peritoneal Mesothelioma.
Katsuya Kato, Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Yukio Takeshima, Kouki Inai

Anticancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and survival analyses of malignant mesothelioma in Japan.
Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Katsuya Kato, Yukio Takeshima, Kouki Inai

Acta Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma.
Vishwa Jeet Amatya, Yukio Takeshima, Keisuke Aoe, Nobukazu Fujimoto, Toshihiro Okamoto, Kouki Inai

Oncol Rep· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National survey of malignant mesothelioma and asbestos exposure in Japan.
Kenichi Gemba, Nobukazu Fujimoto, Katsuya Kato, Keisuke Aoe, Yukio Takeshima, Kouki Inai

Cancer Sci· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma.
Keisuke Aoe, Vishwa Jeet Amatya, Nobukazu Fujimoto, Kei Ohnuma, Osamu Hosono, Kouki Inai

Clin Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
Sonosuke Tanaka, Noboru Hattori, Nobuhisa Ishikawa, Hiroyasu Shoda, Atsushi Takano, Kouki Inai

Int J Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.
Vishwa Jeet Amatya, Yukio Takeshima, Kei Kushitani, Taketo Yamada, Chikao Morimoto, Kouki Inai

Oncol Rep· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency ablation of early breast cancer followed by delayed surgical resection--a promising alternative to breast-conserving surgery.
Shoichiro Ohtani, Mariko Kochi, Mitsuya Ito, Kenji Higaki, Shinichi Takada, Kouki Inai

Breast· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, radiological, and pathological investigation of asbestosis.
Takumi Kishimoto, Katsuya Kato, Hiroaki Arakawa, Kazuto Ashizawa, Kouki Inai

Int J Environ Res Public Health· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
Hidekazu Kohno, Vishwa Jeet Amatya, Yukio Takeshima, Kei Kushitani, Noboru Hattori, Kouki Inai

Oncol Rep· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant pleural mesothelioma detected by spontaneous pneumothorax.
Akari Makidono, Masaki Matsusako, Katsunori Oikado, Yukihisa Saida, Mizuto Otsuji, Kouki Inai

Jpn J Radiol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of apoptosis and immunohistochemical expression of the apoptosis-related proteins in mesothelioma.
Longnan Jin, Vishwa Jeet Amatya, Yukio Takeshima, Looniva Shrestha, Kei Kushitani, Kouki Inai

Hiroshima J Med Sci· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells.
Hiromi Tsukiji, Yukio Takeshima, Vishwa J Amatya, Kei Kushitani, Kouki Inai

Histopathology· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in the serum levels of soluble L, P and E-selectin 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study.
Roya Yaraee, Tooba Ghazanfari, Soghrat Faghihzadeh, Ali Mostafaie, Mohammad R Soroush, Kouki Inai

Int Immunopharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis